37 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
to the arbitrator for injunctive relief until the arbitration award is rendered or the controversy is otherwise resolved. Before an arbitrator is appointed … or makes a final determination on the merits of the controversy, either Party also may, without waiving any remedy under this Agreement, seek from any
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
19 Jul 22
InMed Announces Appointment of Chief Operating Officer
7:43pm
apply to the arbitrator for injunctive relief until the arbitration award is rendered or the controversy is otherwise resolved. Before an arbitrator … is appointed or makes a final determination on the merits of the controversy, either Party also may, without waiving any remedy under this Agreement
424B3
fi3x6to7i7ljo2rb0
6 Jul 22
Prospectus supplement
2:43pm
424B5
wc7jd5u
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
u6fsu6 tw49hin5nm7w
25 Apr 22
Prospectus supplement
5:02pm
424B3
nle8v9z1afr
7 Apr 22
Prospectus supplement
4:46pm
S-3
q4xjp3uufzzl
4 Feb 22
Shelf registration
4:36pm
8-K
EX-2.1
rd2398
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
oryr8ko6e436f3m4j2b0
24 Sep 21
Annual report
7:31am
10-K
EX-2.1
l0qi2ab2y
24 Sep 21
Annual report
7:31am
424B3
1jh1ej1h
22 Jul 21
Prospectus supplement
10:27am